key: cord-0851112-4kh1k1zc
authors: Madi, Nada; Chehadeh, Wassim; Asadzadeh, Mohammed; Al-Turab, Mariam; Al-Adwani, Anfal
title: Analysis of genetic variability of respiratory syncytial virus groups A and B in Kuwait
date: 2018-05-19
journal: Arch Virol
DOI: 10.1007/s00705-018-3881-z
sha: aea1136bae15d1d3b628f228145f6853578f2b55
doc_id: 851112
cord_uid: 4kh1k1zc

Respiratory syncytial virus (RSV) is the most frequently identified viral agent in infants, children, and elderly people with acute respiratory tract infections (ARTIs). This study is the only one of its kind in Kuwait, and its purpose was to investigate the genetic variability of the G protein gene in RSV strains prevalent in Kuwait. Respiratory samples were collected from patients with ARTIs in various hospitals in Kuwait and subjected to reverse transcription PCR (RT-PCR) amplifying a fragment of the G gene of RSV. A total of 305 samples were collected between January and mid-December 2016, and 77 (25.2%) were positive for RSV. Group A viruses were predominant over group B viruses; the RSV-A group was detected in 52 (67.5%) of the positive samples, while the RSV-B group was detected in 25 (32.5%) of the positive samples. Phylogenetic analysis showed that all RSV-A strains grouped into eight clusters of identical sequences of untyped strains. Twelve RSV-B strains, on the other hand, belonged to the RSV-B/BA10 genotype, while the rest were untyped. These data suggest that new and untyped strains of RSV-A group likely predominated in Kuwait and that the BA10 genotype of the RSV-B group became the dominant genotype in the 2016 season.

Respiratory syncytial virus (RSV) is the major pathogen of lower respiratory tract infections (LRTIs), which can be severe in infants, young children, and the elderly [1] . RSV infection is associated with a high rate of morbidity and mortality in children aged < 5 years with acute lower respiratory infections (ALRIs) in both industrialised and developing countries [2] [3] [4] . RSV also is an important virus in adults, causing 25% of lethal respiratory infections in cold seasons, similar to the rate for seasonal influenza [5] . Globally, studies have shown an RSV-associated mortality rate of about 26.5 cases per 100,000 persons/year among adults aged > 65 years [6] .

RSV is a member of the genus Orthopneumovirus, family Pneumoviridae. It has a nonsegmented, negative-sense RNA genome of approximately 15,200 nucleotides encoding 11 structural and non-structural proteins [7] . Of these proteins, the G protein, a type of II attachment glycoprotein of about 300 amino acids in length, is the most variable and is responsible for the differences between RSV genotypes. The G protein has two hypervariable regions, and the C-terminal region (the second hypervariable region) contains strain-specific epitopes [7] [8] [9] . According to the reactivity of RSV with monoclonal antibodies against G glycoprotein, the virus is divided into two major antigenic groups: group A and group B [10, 11] . The RSV-A group is further subdivided into 11 genotypes, GA1-GA7, SAA1, NA1-, NA2 and ON1 [12] [13] [14] , and the RSV-B group is subdivided into 23 genotypes: GB1-GB4, SAB1-SAB3, SAB4, URU1, URU2, BA1-BA12, and THB [12, [15] [16] [17] [18] [19] [20] [21] . This strain variation allows the virus to evade the host's immune responses, which contribute to the capability of the virus to cause frequent re-infections and epidemics and creates a challenge for vaccine development 1 3 [22] . Therefore, it is of great importance to identify the genotypes circulating in the population.

In Kuwait, information regarding the molecular epidemiology of RSV is lacking. The present study is the first one to investigate the genetic diversity and patterns of circulating genotypes of groups RSV-A and RSV-B collected from hospitalised patients with RTIs in comparison with other RSV genotypes circulating worldwide. This information will be beneficial for RSV vaccine development and implementation.

Retrospectively, we analysed patients admitted to different hospitals in Kuwait between January and mid-December 2016 with clinical symptoms of acute upper or lower RTI. Different respiratory samples were collected in the hospital from the patients, including nasopharyngeal aspirates/ washes, tracheal aspirates, and throat swabs. The collected samples were first screened for respiratory viruses, including RSV, using multiplex real-time PCR at the Virology Unit, Faculty of Medicine, Kuwait University. RSV-positive samples were stored frozen at -70 °C for further molecular analysis by specific RSV PCR and phylogenetic analysis after nucleic acid sequencing. Detailed clinical data of the patients could not be obtained from their medical records. 

A One-Step RT-PCR Kit (QIAGEN, GmbH, Hilden, Germany) was used to synthesise cDNA from the extracted RNA according to the manufacturer's instructions. The second hypervariable region of the G protein gene of RSV was amplified using external and semi-nested PCR. External PCR was performed using the forward primer ABG490 and the reverse primer F164. Semi-nested PCR was performed using the forward primer AG655 for group A and forward primer BG517 for group B along with reverse primer F164 as described previously [23] . PCR products of 450/585 and 645 bp for group A/B and BA viruses, respectively, were analysed by 1% agarose gel electrophoresis.

The PCR products were purified using a QIAquick Gel Extraction Kit (QIAGEN) according to the manufacturer's instructions. Subsequently, the purified products were sequenced in the forward and the reverse directions using the forward primer AG655 for group A and BG517 for group B, together with the reverse primer F164. Sequencing was performed using an ABI 3500/3500xL Genetic Analyzer (PE Applied Biosystems Inc., Foster City, CA, USA) with an ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems Inc., USA).

The obtained nucleic acid sequences of the second hypervariable region of the G protein gene of RSV were edited manually and aligned with the available RSV sequences from the GenBank database (https ://www.ncbi.nlm.nih.gov/) using the Clustal W method in MEGA software version 7 [24] . Phylogenetic trees were constructed using the neighbourjoining method, and bootstrap values with 1,000 replicates were calculated in MEGA software version 7. Pairwise distances between and within the genotypes of groups RSV-A and RSV-B at the nucleotide level were calculated using the Tamura-Nei Model. Reference strains representing each known genotype of RSV group A and group B were retrieved from GenBank and included in the trees. Fifteen published reference sequences of RSV group A and 27 reference sequences of RSV group B were used for comparison to the sequences obtained in this study. Online Resources 1 and 2 contain the GenBank accession numbers of RSV group A and RSV group B reference sequences used in the current study. Figure 1 , was as follows: < 12 months, 51 (66%); 1-5 years, 13 (17%); 6-13 years, 2 (3%); 14-28 years, 1 (1%); 28-60 years, 2 (3%); > 60 years, 8 (10%). The seasonal distribution of RSV-A and RSV-B in Kuwait is shown in Figure 2 , with the peak of positivity being detected in January 2016 and the lowest positivity detected in February 2016.

The sequences from 46 RSV group A and 22 group B Kuwaiti strains collected from the patients were included in a phylogenetic analysis, which revealed that the 46 RSV-A strains were untyped and did not belong to any of the known group A genotypes (Fig. 3A ). Among these untyped Kuwaiti strains, 18 (39%) were found to form eight clusters with identical sequences, with two to three sequences per cluster, while the remaining 28 (61%) strains were sporadic single strains (Fig. 3A) . The divergence between prototype strain A2 and the Kuwaiti strains ranged from 6% to 22% at the nucleotide level, while differences of up to 19% were observed among all group A Kuwaiti strains. Moreover, strains in clusters 5 and 6 were genetically closer to the ON1 reference strain than strains in other clusters; the differences in the nucleotide sequence between strains in clusters 5 and 6 and ON1 ranged from 0.5% to 3%, while the differences in the nucleotide sequences between strains from other clusters and ON1 ranged from 0.5% to 16%. Furthermore, the KW-827 and KW-1411 strains were genetically closer to the NA1 reference strain than other Kuwaiti strains. The nucleotide sequence difference between the NA1 reference strain and the KW-827 and KW-1411 strains was 3% and 2%, respectively. However, the differences in the nucleotide sequences between the NA1 reference strain and the rest of Kuwaiti strains ranged from 16% to 19%. The 22 RSV group B Kuwaiti strains clustered into four groups. Twelve (55%) strains clustered with the BA10 genotype with bootstrap values of 65% to 85%, and the divergence in the nucleotide sequences ranged from 0% to 4% between the Kuwaiti strains and BA10 references strains. The remaining 10 (45%) Kuwaiti strains were clustered into three groups of untyped strains that do not belong to any of the known group B genotypes (Fig. 3B ). Among these clusters, cluster 2 contained three identical sequences and one divergent strain with nucleotide sequence differences ranging from 0.4% to 1%. Moreover, there was 3.5% to 7% divergence at the nucleotide level between the Kuwaiti strains and the prototype BA strain, while up to 7% differences in the nucleotide sequences were observed among all group B Kuwaiti strains.

RSV is the most common viral pathogen causing acute lower respiratory tract infections in infants, children and older people. The present study is the first to investigate the frequency and genetic variability of RSV group A and group B in patients with ARTI in Kuwait. A total of 305 samples from ARTI patients, including infants, children and adults, were collected, and 77 (25.2%) of the patients [35] . In this study, however, we were unable to investigate the association between RSV groups or coinfections on the severity of the RSV respiratory diseases due to the lack of clinical data for the patients.

Since little is known about the distribution of RSV infection in different age groups, in this study we analysed the age distribution of the patients with RSV infections. Our results showed that infants less than one year of age represented that largest proportion of patients with RSV infections (66%), followed by children between one and five years old (17%). The prevalence decreased to 3% in children between six and 13 years old and further decreased to only 1% in children and adults between 14 to 28 years old. Many other studies have also demonstrated a high incidence of RSV infection and disease among infants less than one year old [36, 37] . a recent epidemiological meta-analysis study implicated RSV as one of the most significant pathogens of early childhood and placed it as the second-most-likely single pathogen to cause death in children less than one year of age [38] [39] [40] . Although there is evidence that maternal antibodies in infants are likely to be important in protection against RSV disease, severe disease was noted in children under six months of age, indicating that maternal RSV-specific antibodies are protective during the first 6-7 months, but this protection may then wane [41] . There are other risk factors known to predispose infants to RSV-associated disease, including physical and immunological immaturity, which Solid triangles indicate the sequences of the reference strains. Details for the reference GenBank sequences used for phylogenetic analysis are given in Table 1 and Table 2 for RSV-A and RSV-B strains, respectively. The scale bar indicates the proportion of nucleotide substitutions, and the numbers at the branches are bootstrap values determined for 1,000 repetitions. Bootstrap values greater than 50% are shown at the branches. The evolutionary distances were computed using the Tamura-Nei method and are in units of base substitutions per site ▸ causes infants younger than three months to be the most susceptible to severe disease. Also, the size of the airway is specifically problematic in neonates and young infants because obstruction from sloughed epithelium, fibrin, inflammatory debris, and mucus is a significant factor in disease pathogenesis. In fact, the period after birth is critical in the development of the lung architecture and cellular functions, including the development of immunological effector mechanisms to deal with commensal and pathogenic microorganisms [42] [43] [44] . It has been shown that an immune system that is weak in the early years will mature sooner when children are re-infected for the second or third time [45] . Our results showed that the prevalence of RSV infection reached 10% in patients > 60 years old, whose immune response is weakened by age. Similar observations have been made in other studies [46] [47] [48] [49] [50] . Researchers have found that infants infected with RSV develop maternal antibodies that recognise both the F and G proteins. However, in older infants, there is a dramatic increase in antibodies recognizing the G protein, while infection provokes only a modest increase in antibodies against the F protein. It was also shown that antibodies against the F protein continue to increase with age, whereas those against the G protein decrease [51] . RSV infection is characterised by a seasonality that may be associated with region and climate. Many studies have shown that RSV infection in non-tropical countries occurs almost year-round and peaks mainly during winter [47, [52] [53] [54] , which is different from what has been reported in tropical countries [55] . In our study, however, RSV infection was detected in patients in autumn to spring (November to February) but peaked in winter (January), a result that is in coordinance with studies conducted in non-tropical countries. The cold and sometimes dry conditions of the winter season in Kuwait favour survival of RSV in the environment and encourage people to crowd together indoors, which may increase the chance of parents and older siblings acquiring RSV infection and passing it on to infants in the home. Also, the cold and relative humidity conditions in winter might delay the drying of large respiratory droplets, which could favour RSV survival and transmission, since RSV is predominantly transmitted through large droplets [56] .

Interestingly, phylogenetic analysis showed that all RSV-A strains collected from the patients in this study were untyped strains that did not belong to any of the known group A genotypes in the Genbank database. Furthermore, the data showed that these Kuwaiti strains formed different clusters of identical sequences. These data indicate that there is heterogeneity among the Kuwaiti strains, which differ from the known RSV-A genotypes. One can speculate that these are new strains or that they originate through recombination of other known strains. Whole-genome sequencing of these isolates is necessary to address this question. Although they were untyped, RSV-A Kuwaiti strains in cluster 5 (Fig. 3A) were more closely related to the new RSV-A/ON1 genotype than the rest of the Kuwaiti strains according to the percentage of differences in the nucleotide sequences. RSV-A/ON1 is novel genotype that was first described by Eshaghi et al. in Ontario, Canada [57] , and this strain later emerged and became the dominant genotype in different countries, including northern Italy, Germany, Thailand, Turkey, and Saudi Arabia [16, 19, 30, 47, 54, [58] [59] [60] [61] . A further significant result is that the two Kuwaiti strains (KW-1411 and KW-827) were more closely related to the RSV-A/NA1 strain than other Kuwaiti strains based on pairwise nucleotide distances. The RSV-A/NA1 genotype and the NA2 genotype are new variants of A2 genotype that caused large epidemics in Japan during the 2005-2006 and 2006-2007 seasons because of the lack of immunity in the children [62] . Also, the AN1 genotype was a dominated genotype in India among children < 6 years old during the period 2009-2012 [28] and in Italy among children < 3 years old during 2006-2012 [63] . Moreover, between October and December 2014, NA1 and ON1 genotypes of group A RSV dominated in Riyadh, Saudi Arabia, among children less than five years of age with ARI symptoms [30] .

In this study, the RSV-B/BA10 genotype was the predominant genotype among Kuwaiti RSV-B strains, while the rest of the Kuwaiti RSV-B strains formed three clusters of untyped strains. RSV-B/BA genotypes emerged in the late 1990s and then spread globally and became the predominant genotypes [64] . Many studies have divided members in the BA clade into 13 different genotypes. However, other studies disagree on the total number of genotypes because they use different reference sequences for the genotypes. Therefore, there is overlap between genotypes, as evidenced by a partial CDS tree [65] . In our study, in the phylogenetic tree, we used different BA reference sequences that represented BA1 to BA10, and it was easily to identify the BA10 strains in particular. Previous studies have also demonstrated the predominance of RSV-B/BA genotypes, which is in line with our findings [17, 19, 25, 66, 67] . Interestingly, some reports have shown that genotype BA had replaced other prevailing genotypes in certain places, such as Argentina and India [21, 23] . It has been speculated that antigenic changes in the G protein and the evasion of host immune responses had led to the selective advantage of genotype BA viruses over other RSV-B genotypes [21] .

In summary, the findings of this study provide vital information regarding the frequency of RSV infection among patients of different age with ARTI in Kuwait. Sequence analysis of the circulating strains demonstrated the predominance of the RSV-A group over the RSV-B group in these patients. Additionally, the circulating RSV-A strains were untyped strains, indicating heterogenicity among group A RSV strains. On the other hand, most of the strains of the RSV-B group belonged to the BA10 genotype, showing the predominance of this genotype among patients with ARTI in Kuwait. We are firmly recommending whole-genome sequencing of the untyped Kuwaiti strains for full strain characterisation, which will be accomplished in the next project. Further surveillance and sequencing of RSV strains are required to determine if these untyped Kuwaiti strains are still circulating in this region and if the dominance of certain RSV genotypes over others is sustained over time or fluctuates from year to year. The knowledge obtained in the study may be beneficial for the development of a future vaccine against RSV.

Complete genome sequence of human respiratory syncytial virus genotype A with a 72-nucleotide duplication in the attachment protein G gene

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis

Viral etiology of hospitalized acute lower respiratory infections in children under 5 years of age-a systematic review and meta-analysis

Molecular epidemiology of human respiratory syncytial virus in Iran

Mortality associated with influenza and respiratory syncytial virus in the United States

Molecular epidemiology of respiratory syncytial virus

Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein

Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus

Two distinct subtypes of human respiratory syncytial virus

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community

Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America

Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: Identification of new subgroup A and B genotypes

A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype

Identification of genotype ON1 and a new subgroup B genotype in Thailand

Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea

Genotypes of respiratory syncytial virus group B identified in Uruguay

New genotypes within respiratory syncytial virus group B genotype BA in Niigata

Displacement of predominant respiratory syncytial virus genotypes in Malaysia between

Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication

Immunity to and frequency of reinfection with respiratory syncytial virus

Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India

MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets

Genetic variability of respiratory syncytial viruses (RSV) Prevalent in southwestern china from 2006 to 2009: Emergence of subgroup B and A RSV as dominant strains

Genetic variability of group A and B human respiratory syncytial viruses isolated from 3 provinces in China

Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital

Molecular characterization of human respiratory syncytial virus NA1 and GA5 genotypes detected in Assam in northeast India

Epidemiology of 11 respiratory RNA viruses in a cohort of hospitalized children in Riyadh, Saudi Arabia

Co-circulation of 72 bp duplication group A and 60 bp duplication group B respiratory syncytial virus (RSV) strains in Riyadh, Saudi Arabia during 2014

Respiratory syncytial virus coinfections with rhinovirus and human bocavirus in hospitalized children. Med (United States) 94:e1788

Dual respiratory virus infections

Human rhinovirus and disease severity in children

Coinfections of the respiratory tract: Viral competition for resources

Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

Bronchiolitisassociated hospitalizations among US children

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study

Determinants of early life immune responses to RSV infection

Acute viral respiratory infections among children in MERS-endemic Riyadh

The level and duration of RSV-specific maternal IgG in infants in kilifi Kenya

Structural aspects of postnatal lung development-alveolar formation and growth

Early lung development: lifelong effect on respiratory health and disease

Ontogeny of early life immunity

Respiratory syncytial virus

Clinical and epidemiologic characteristics of hospitalized patients with laboratoryconfirmed respiratory syncytial virus infection in eastern China between 2009 and 2013: a retrospective study

Genetic variability human respiratory syncytial virus subgroups A and B in Turkey during six successive epidemic seasons

Viral etiologies of hospitalized acute lower respiratory infection patients in China

The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand

Epidemiology of respiratory syncytial virus infection in rural and urban Kenya

Antigenic fingerprinting following primary RSV infection in young children identifies novel antigenic sites and reveals unlinked evolution of human antibody repertoires to fusion and attachment glycoproteins

Prevalence of respiratory syncytial virus group B genotype BA-IV strains among children with acute respiratory tract infection in Kolkata, Eastern India

Epidemiology of respiratory syncytial virus in children in Cyprus during three consecutive winter seasons (2010-2013): age distribution, seasonality and association between prevalent genotypes and disease severity

Novel respiratory syncytial virus (RSV) genotype ON1 predominates in germany during winter season 2012-13

Respiratory syncytial virus infection in tropical and developing countries

Modes of transmission of respiratory syncytial virus

Genetic variability of human respiratory syncytial virus a strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication

Characteristics and their clinical relevance of respiratory syncytial virus types and genotypes circulating in Northern Italy in five consecutive winter seasons

Rapid spread of the novel respiratory syncytial virus a on1 genotype, central Italy

Molecular epidemiology of human respiratory syncytial virus over three consecutive seasons in Latvia

Genetic variability of human respiratory syncytial virus in Pune, Western India

Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan

Phylogeny and population dynamics of respiratory syncytial virus (Rsv) A and B

Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides

Sequencing and analysis of globally obtained human respiratory syncytial virus a and B genomes

Molecular characterization of human respiratory syncytial virus subtype B: a novel genotype of subtype B circulating in China

Molecular evolution of attachment glycoprotein (G) gene in human respiratory syncytial virus detected in Japan

Acknowledgements This work was supported by an initiation Grant from the Research Sector, Kuwait University, Kuwait (Grant no: ZM04/16).

Conflict of interest The authors declare that they have no competing interests.